News
Stockhead on MSN22m
Health Check: Cancer drug developers drive further positive Car-T resultsTwo of the leading developers of Car-T immuno-oncology drugs, Imugene and Chimeric have unveiled further positive trial ...
MyChesCo on MSN1h
Orchestra BioMed Secures $70 Million in Strategic Investments to Advance Cardiology PipelineNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced $70 million in new capital commitments from Ligand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback